Takeshi Harita

Long-Term (&gt;10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly- <i>l</i> -Lactic Acid Coronary Stents

Soji Nishio, Kunihiko Kosuga, Keiji Igaki et al. · Circulation · 2012 · 237 citations

Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation

Yuta Yamamoto, Takeru Makiyama, Takeshi Harita et al. · Human Molecular Genetics · 2017 · 86 citations · Full text

Cardiac Muscle, Genetics, Disease Gene Identification +16

Gene-Based Risk Stratification for Cardiac Disorders in <i>LMNA</i> Mutation Carriers

Suguru Nishiuchi, Takeru Makiyama, Takeshi Aiba et al. · Circulation Cardiovascular Genetics · 2017 · 78 citations · Full text

Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia

Kenichi Sasaki, Takeru Makiyama, Yoshinori Yoshida et al. · PLoS ONE · 2016 · 65 citations · Full text

Complex aberrant splicing in the induced pluripotent stem cell–derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation

Yimin Wuriyanghai, Takeru Makiyama, Kenichi Sasaki et al. · Heart Rhythm · 2018 · 45 citations

Kcnq1-a344aspl Mutation, Long Qt Syndrome, Transcriptional Regulation +12